KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa05214
|
Glioma |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
2.57E-6 |
hsa05218
|
Melanoma |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
4.17E-6 |
hsa05220
|
Chronic myeloid leukemia |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
5.20E-6 |
hsa05219
|
Bladder cancer |
CCND1,CDK4,CDKN1A,TP53, |
4.25E-5 |
hsa05223
|
Non-small cell lung cancer |
CCND1,CDK4,AKT1,TP53, |
9.09E-5 |
|
hsa04115
|
p53 signaling pathway |
CCND1,CDK4,CDKN1A,TP53, |
1.81E-4 |
hsa05212
|
Pancreatic cancer |
CCND1,CDK4,AKT1,TP53, |
2.15E-4 |
hsa05222
|
Small cell lung cancer |
CCND1,CDK4,AKT1,TP53, |
3.40E-4 |
hsa05215
|
Prostate cancer |
CCND1,CDKN1A,AKT1,TP53, |
4.03E-4 |
hsa04110
|
Cell cycle |
CCND1,CDK4,CDKN1A,TP53, |
1.09E-2 |
hsa05200
|
Pathways in cancer |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
1.65E-2 |
hsa05213
|
Endometrial cancer |
CCND1,AKT1,TP53, |
3.52E-2 |
hsa05210
|
Colorectal cancer |
CCND1,AKT1,TP53, |
9.00E-2 |
hsa04350
|
TGF-beta signaling pathway |
BMPR2,LEFTY1,LEFTY2, |
9.63E-2 |
hsa05216
|
Thyroid cancer |
CCND1,TP53, |
5.02E-1 |
hsa05221
|
Acute myeloid leukemia |
CCND1,AKT1, |
9.81E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0008361
|
regulation of cell size |
TP63,CDK4,LEFTY1,CDKN1A,AKT1,LEFTY2,TP53, |
3.14E-8 |
GO:0032535
|
regulation of cellular component size |
TP63,CDK4,LEFTY1,CDKN1A,AKT1,LEFTY2,TP53, |
1.60E-7 |
GO:0042127
|
regulation of cell proliferation |
CCND1,BMPR2,TOB2,TAC1,TP63,CDK4,CDKN1A,TP53, |
5.25E-6 |
GO:0000082
|
G1/S transition of mitotic cell cycle |
CCND1,CDK4,CDKN1A,AKT1, |
2.36E-5 |
GO:0009411
|
response to UV |
CCND1,CDKN1A,AKT1,TP53, |
2.77E-5 |
|
GO:0045596
|
negative regulation of cell differentiation |
CCND1,TOB2,ABCA1,TP63,TP53, |
5.58E-5 |
GO:0009991
|
response to extracellular stimulus |
CCND1,BMPR2,CDKN1A,AKT1,TP53, |
5.99E-5 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
CCND1,BMPR2,NR2F2,TP63,CDK4,AKT1,TP53, |
1.22E-4 |
GO:0045792
|
negative regulation of cell size |
TP63,CDKN1A,AKT1,TP53, |
1.30E-4 |
GO:0051329
|
interphase of mitotic cell cycle |
CCND1,CDK4,CDKN1A,AKT1, |
1.46E-4 |
GO:0051325
|
interphase |
CCND1,CDK4,CDKN1A,AKT1, |
1.59E-4 |
GO:0007166
|
cell surface receptor linked signal transduction |
CCND1,BMPR2,CCL5,TAC1,ABCA1,TP63,LEFTY1,AKT1,LEFTY2, |
1.71E-4 |
GO:0051726
|
regulation of cell cycle |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
2.90E-4 |
GO:0009416
|
response to light stimulus |
CCND1,CDKN1A,AKT1,TP53, |
3.48E-4 |
GO:0009725
|
response to hormone stimulus |
CCND1,CCL5,TAC1,CDKN1A,AKT1, |
4.29E-4 |
GO:0009628
|
response to abiotic stimulus |
CCND1,TAC1,CDKN1A,AKT1,TP53, |
4.34E-4 |
GO:0031328
|
positive regulation of cellular biosynthetic process |
NR2F2,ABCA1,TP63,CDK4,AKT1,TP53, |
4.47E-4 |
GO:0009891
|
positive regulation of biosynthetic process |
NR2F2,ABCA1,TP63,CDK4,AKT1,TP53, |
4.78E-4 |
GO:0048145
|
regulation of fibroblast proliferation |
CDK4,CDKN1A,TP53, |
5.80E-4 |
GO:0009719
|
response to endogenous stimulus |
CCND1,CCL5,TAC1,CDKN1A,AKT1, |
6.24E-4 |
GO:0008284
|
positive regulation of cell proliferation |
CCND1,TAC1,TP63,CDK4,CDKN1A, |
6.78E-4 |
GO:0001558
|
regulation of cell growth |
TP63,CDKN1A,AKT1,TP53, |
9.40E-4 |
GO:0031667
|
response to nutrient levels |
CCND1,BMPR2,AKT1,TP53, |
9.83E-4 |
GO:0009314
|
response to radiation |
CCND1,CDKN1A,AKT1,TP53, |
1.02E-2 |
GO:0042493
|
response to drug |
CCND1,CCL5,CDKN1A,TP53, |
1.28E-2 |
GO:0000079
|
regulation of cyclin-dependent protein kinase activity |
CCND1,CDKN1A,AKT1, |
1.38E-2 |
GO:0008629
|
induction of apoptosis by intracellular signals |
TP63,CDKN1A,TP53, |
1.38E-2 |
GO:0032270
|
positive regulation of cellular protein metabolic process |
CCND1,BMPR2,CDK4,AKT1, |
1.59E-2 |
GO:0051247
|
positive regulation of protein metabolic process |
CCND1,BMPR2,CDK4,AKT1, |
1.79E-2 |
GO:0051240
|
positive regulation of multicellular organismal process |
BMPR2,CCL5,TAC1,AKT1, |
1.82E-2 |
GO:0031668
|
cellular response to extracellular stimulus |
BMPR2,CDKN1A,TP53, |
1.93E-2 |
GO:0022402
|
cell cycle process |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
2.15E-2 |
GO:0033554
|
cellular response to stress |
CCND1,BMPR2,TP63,CDKN1A,TP53, |
2.16E-2 |
GO:0003006
|
reproductive developmental process |
CCND1,TP63,AKT1,LEFTY2, |
2.23E-2 |
GO:0007389
|
pattern specification process |
BMPR2,NR2F2,TP63,LEFTY2, |
2.35E-2 |
GO:0051094
|
positive regulation of developmental process |
BMPR2,CCL5,TOB2,AKT1, |
2.64E-2 |
GO:0051384
|
response to glucocorticoid stimulus |
CCND1,CCL5,CDKN1A, |
2.85E-2 |
GO:0042770
|
DNA damage response, signal transduction |
CCND1,TP63,TP53, |
3.00E-2 |
GO:0070141
|
response to UV-A |
CCND1,AKT1, |
3.10E-2 |
GO:0031960
|
response to corticosteroid stimulus |
CCND1,CCL5,CDKN1A, |
3.38E-2 |
GO:0051173
|
positive regulation of nitrogen compound metabolic process |
NR2F2,ABCA1,TP63,AKT1,TP53, |
3.47E-2 |
GO:0010557
|
positive regulation of macromolecule biosynthetic process |
NR2F2,TP63,CDK4,AKT1,TP53, |
3.67E-2 |
GO:0030308
|
negative regulation of cell growth |
TP63,CDKN1A,TP53, |
3.94E-2 |
GO:0040008
|
regulation of growth |
TP63,CDKN1A,AKT1,TP53, |
4.70E-2 |
GO:0007167
|
enzyme linked receptor protein signaling pathway |
BMPR2,LEFTY1,AKT1,LEFTY2, |
4.73E-2 |
GO:0007178
|
transmembrane receptor protein serine/threonine kinase signaling pathway |
BMPR2,LEFTY1,LEFTY2, |
4.92E-2 |
GO:0002347
|
response to tumor cell |
TP63,TP53, |
5.16E-2 |
GO:0010033
|
response to organic substance |
CCND1,CCL5,TAC1,CDKN1A,AKT1, |
5.21E-2 |
GO:0043066
|
negative regulation of apoptosis |
TP63,CDKN1A,AKT1,TP53, |
5.21E-2 |
GO:0045892
|
negative regulation of transcription, DNA-dependent |
ARID4A,NR2F2,TP63,TP53, |
5.30E-2 |
GO:0043069
|
negative regulation of programmed cell death |
TP63,CDKN1A,AKT1,TP53, |
5.42E-2 |
GO:0060548
|
negative regulation of cell death |
TP63,CDKN1A,AKT1,TP53, |
5.46E-2 |
GO:0051253
|
negative regulation of RNA metabolic process |
ARID4A,NR2F2,TP63,TP53, |
5.55E-2 |
GO:0007568
|
aging |
CCL5,TP63,TP53, |
5.59E-2 |
GO:0045926
|
negative regulation of growth |
TP63,CDKN1A,TP53, |
5.59E-2 |
GO:0000278
|
mitotic cell cycle |
CCND1,CDK4,CDKN1A,AKT1, |
5.90E-2 |
GO:0042592
|
homeostatic process |
CCL5,TAC1,ABCA1,AKT1,TP53, |
6.02E-2 |
GO:0006974
|
response to DNA damage stimulus |
CCND1,TP63,CDKN1A,TP53, |
6.03E-2 |
GO:0014070
|
response to organic cyclic substance |
CCND1,TAC1,CDKN1A, |
6.73E-2 |
GO:0007049
|
cell cycle |
CCND1,CDK4,CDKN1A,AKT1,TP53, |
6.77E-2 |
GO:0022403
|
cell cycle phase |
CCND1,CDK4,CDKN1A,AKT1, |
8.05E-2 |
GO:0045737
|
positive regulation of cyclin-dependent protein kinase activity |
CCND1,AKT1, |
8.25E-2 |
GO:0030857
|
negative regulation of epithelial cell differentiation |
CCND1,TP63, |
8.25E-2 |
GO:0043065
|
positive regulation of apoptosis |
TP63,CDKN1A,AKT1,TP53, |
8.93E-2 |
GO:0043068
|
positive regulation of programmed cell death |
TP63,CDKN1A,AKT1,TP53, |
9.11E-2 |
GO:0010942
|
positive regulation of cell death |
TP63,CDKN1A,AKT1,TP53, |
9.22E-2 |
|
|
|
|
|
|